驱动力(838275) - 投资者关系活动记录表

Group 1: Investor Relations Activity Overview - The investor relations activity was held on December 5, 2024, at the company meeting room, attended by various investment firms and individual investors [2] - Key personnel present included the Chairman and General Manager Liu Pingxiang, controlling shareholder Liu Jinping, Board Secretary Ye Junqiang, and Deputy Financial Director Yang Na [3] Group 2: Company Business and Market Insights - The company has previously engaged in the pet food sector, specifically cat food aimed at enhancing immunity, but this segment currently represents a very small portion of its overall business [4] - There is significant market demand for hematopoietic nutritional products due to modern farming practices leading to anemia in livestock, which affects growth and meat quality [5] - The company's main business involves the research, production, and sales of additives that enhance animal blood production, but its current market share remains relatively small [6] Group 3: Financial Performance and Projections - The company's gross profit margin increased in the first three quarters of 2024 due to a strategic focus on higher-margin products, despite a decline in lower-margin product sales [7] - Although revenue has decreased this year, net profit has risen, attributed to improved sales structure and reduced credit impairment losses, among other factors [8] - The company aims to continue driving innovation and market expansion to deliver better returns to investors [9]